ProductUpdated on 20 October 2025
AI-Powered Vaccine Management
Co-founder and CEO of SMRTmeds | MSc in Immunology @ Oxford
Madrid, Spain
About
At SMRTmeds, we are developing an AI-powered tool to predict the immune response after a vaccine and more efficiently manage booster schedules. We use a panel of immune biomarkers and novel machine learning algorithms to integrate and personalize vaccination today. We are looking for any kind of opportunity, from potential links to early-stage investors, industry partners, hospital pilot agreements, and advisors. Please reach out!
Looking for
- Distribution Partner
- Publisher
- Wholesaler
- Importer
Applies to
- Biotech and Lifescience
- Medtech
Similar opportunities
Partnership
Collaboration in Immune Biomarker Discovery & Tech Transfer
- Research
- Business
- Data analysis
- Joint development
- Knowledge transfer
- Technology transfer
- Testing of technology
Carlos Valverde
Co-founder and CEO of SMRTmeds | MSc in Immunology @ Oxford
Madrid, Spain
Product
- Medtech
- Importer
- Biotech and Lifescience
Ángel Ricardo Rodríguez Pérez
Medical Doctor
Madrid, Spain
Expertise
Silk-based biosensor platforms.
Nahla Jemni Damer
Director of Research and Development at Silk Biomed SL | Regenerative Medicine & Neuroscience
Madrid, Spain